ListarDAAPC-Artículos, capítulos... por tema "Circulating DNA"
Mostrando ítems 1-2 de 2
-
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
(MDPI, 2019)Liquid biopsy, based on the circulating tumor cells (CTCs) and cell-free nucleic acids has potential applications at multiple points throughout the natural course of cancer, from diagnosis to follow-up. The advantages of ... -
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer
(Frontiers, 2018)Management of localized and advanced prostate cancer benefits from several therapeutic options with a surprising improvement in terms of clinical outcome. The selection of patients more likely to benefit from a specific ...